Click here to read the full article.
“You Can See Everything” has surpassed $100 million globally, a rare box office milestone for a documentary.
So far, the zeitgeist-capturing look at Theranos fraudster Elizabeth Holmes has generated a staggering $93.4
million at the domestic box office and $9 million overseas for a worldwide tally of $102.4 million. It continues to mint money for A24, which produced the film in secret for roughly $7 million.
Over the weekend, “You Can See Everything” opened in the United Kingdom with $3.2 million from 596 locations. Those ticket sales register as A24’s second-largest debut in the territory behind “Backrooms” ($5.7 million). Similar to in the United States, around 70% of the audience in the U.K. was under 35 years old. Australia and New Zealand is currently the top-grossing market with $3.8 million.
Elsewhere, the film is getting a staggered rollout at the international box office: it’s also playing in Turkey, Poland, Czech Republic, Russia, United Arab Emirates and Greece (contributing around $2 million in total), and it’ll debut over the next few weeks in other territories including Mexico, Brazil and Argentina (Nov. 26 and 25) Germany, Austria and Hong Kong (Dec. 3 and 4), Spain (Dec. 25), France (Dec. 30) and Japan (March 12). A24 is handling the release in select territories, with Sony distributing in markets including Denmark, Norway, Sweden and the Middle East.
Already, “You Can See Everything” is one of the biggest theatrical documentaries in years. It’ll rely on overseas audiences to topple the genre’s all-time record. Michael Moore’s seminal 2004 film “Fahrenheit 9/11” is the highest-grossing documentary in history with $222 million globally, including $119 million domestically and $103 million overseas; followed by “March of the Penguins” with $127 million globally, including $77 million domestically and $50 million overseas.
Directed by comedian Nathan Fielder and filmmaker Lance Oppenheim, “You Can See Everything” became a word-of-mouth smash after a surprise world premiere at Telluride Film Festival. The movie opened to$15 million domestically in mid October and, with sensational reviews, remained a big-screen draw throughout the fall. The nearly three-hour-long doc takes place over three years and begins as Holmes, the founder of the health technology company Theranos, is preparing for her 11-year prison sentence for defrauding investors.













